Our previous studies reported that HLF transactivates c-Jun to enhance the tumor-initiating cell (TICs)-like properties of hepatoma cells, thus promoting HCC progression and sorafenib resistance [12]. The gene discussed is JUN; the disease is hepatocellular carcinoma.